Clinical trials update of the European Organization for Research and Treatment of Cancer Breast Cancer Group

Emiel J.Th Rutgers*, Philip Meijnen, Hervé Bonnefoi

*Corresponding author for this work

Research output: Contribution to journalReview articleAcademicpeer-review

Abstract

The present clinical trial update consists of a review of two of eight current studies (the 10981-22023 AMAROS trial and the 10994 p53 trial) of the European Organization for Research and Treatment of Cancer Breast Cancer Group, as well as a preview of the MIND-ACT trial. The AMAROS trial is designed to prove equivalent local/regional control for patients with proven axillary lymph node metastasis by sentinel node biopsy if treated with axillary radiotherapy instead of axillary lymph node dissection, with reduced morbidity. The p53 trial started to assess the potential predictive value of p53 using a functional assay in yeast in patients with locally advanced/inflammatory or large operable breast cancer prospectively randomised to a taxane regimen versus a nontaxane regimen.

Original languageEnglish
Pages (from-to)165-169
Number of pages5
JournalBreast Cancer Research
Volume6
Issue number4
DOIs
Publication statusPublished - Jul 2004

Cite this